Dachaigh › Diabetes Type 1 › Washington
Sgrùdaidhean clionaigeach Diabetes Type 1 ann an Washington
Tha 20 sgrùdaidhean airson Diabetes Type 1 a’ lorg phàirtichean aig làraichean ann an Washington.
Bailtean ann an Washington
Teacsa sgrùdaidh oifigeil (Beurla)
Type 1 Diabetes Extension Study
- Benaroya Research Institute, Seattle
A’ fastadhSgrùdadh amharc
Aoisean 8 gu 35 · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT02734277METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
A’ fastadhÌre 2
Aoisean 18 gu 69 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07699380A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
- MultiCare Mary Bridge Children's Health Center- Site Number : 8400037, Tacoma
A’ fastadhÌre 3
Aoisean 1 gu 25 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
A’ fastadhÌre 1/2
Aoisean 12 gu 35 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06783309Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- Benaroya Research Institute, Seattle
A’ fastadhÌre 2
Aoisean 4 gu 34 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Benaroya Research Institute, Seattle
A’ fastadhÌre 2
Aoisean 8 gu 45 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- Seattle Children's Hospital, Seattle
A’ fastadhÌre 1/2
Aoisean 9 gu 20 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07061574SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason, Seattle
- Mary Bridge Children's Outpatient Center - Tacoma, Tacoma
A’ fastadhÌre 2
Aoisean 5 gu 40 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Washington, Seattle
A’ fastadh
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 16 Iuch 2026 · NCT06880835Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Ògmh 2026 · NCT05822609Kidney Precision Medicine Project
- University of Washington, Seattle
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Gibl 2026 · NCT04334707Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
- Rainier Clinical Reseach Center, Renton
A’ fastadh
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 9 Gibl 2026 · NCT07296276Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
- Rainier Clinical Research Center, Renton
A’ fastadhÌre 2
Aoisean 18 gu 50 · Gach gnè · Air ùrachadh 6 Gibl 2026 · NCT06964087Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 24 Màrt 2026 · NCT06217302Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
A’ fastadhÌre 3
Aoisean 18 gu 49 · Gach gnè · Air ùrachadh 4 Màrt 2026 · NCT05819138Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
- Seattle Children's, Seattle
A’ fastadh
Aoisean 16 gu 19 · Gach gnè · Air ùrachadh 30 Dùbh 2025 · NCT07292558EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
- Benaroya Research Institute, Seattle
A’ fastadhSgrùdadh amharc
Suas gu aois 70 · Gach gnè · Air ùrachadh 19 Dùbh 2025 · NCT03369821InvesT1D: Promoting Adolescent Investment in Diabetes Care
- Seattle Children's, Seattle
A’ fastadh
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 16 Dùbh 2025 · NCT06384911TrialNet Pathway to Prevention of T1D
- Benaroya Research Institute, Seattle
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 2 gu 45 · Gach gnè · Air ùrachadh 1 Iuch 2025 · NCT00097292MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
A’ fastadhÌre 1
Aoisean 12 gu 25 · Gach gnè · Air ùrachadh 13 Ògmh 2025 · NCT05065372Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.